Zhongyuan Union Cell & Gene Engineering

Zhongyuan Union Cell & Gene Engineering Corp., Ltd. (Vcanbio) is a prominent Chinese biotechnology company focused on the industrialization of cell therapy and gene technology. Headquartered in Tianjin, the company operates an extensive network of stem cell banks across China, providing storage services for cord blood, umbilical cord, and adipose-derived stem cells. Beyond storage, Vcanbio is actively developing a pipeline of regenerative medicine products and CAR-T cell therapies targeting oncology and autoimmune disorders. The company also provides comprehensive genetic testing and molecular diagnostic services to support precision medicine. Publicly traded on the Shanghai Stock Exchange, Vcanbio integrates R&D, manufacturing, and clinical application to lead the cell and gene engineering sector in the Asia-Pacific region.